Information  X 
Enter a valid email address

GlaxoSK Capital PLC (AG99)

  Print      Mail a friend

Monday 27 October, 2014

GlaxoSK Capital PLC

Publication of Supplementary Prospectus

RNS Number : 4157V
GlaxoSmithKline Capital PLC
27 October 2014
 



Publication of Supplementary Prospectus

 

The following Supplementary Prospectus dated 27 October 2014, supplementing the Base Prospectus dated 4 August 2014, has been approved by the UK Listing Authority and is available for viewing:

GlaxoSmithKline plc and GlaxoSmithKline Capital plc

£15,000,000,000 Euro Medium Term Note Programme

 

Copies of the Supplementary Prospectus and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

 http://www.morningstar.co.uk/uk/NSM.

The Supplementary Prospectus will also be available for viewing at:

http://www.gsk.com/en-gb/investors/stock-exchange-announcements/

For further information, please contact:

GlaxoSmithKline plc

980 Great West Road

Brentford

Middlesex

TW8 9GS

United Kingdom

 

Enquiries:

UK Media enquiries:

David Mawdsley

Simon Steel

(020) 8047 5502

(020) 8047 5502

 

European Analyst/Investor enquiries:

Gary Davies

Ziba Shamsi

 (020) 8047 5503

 (020) 8047 5543

BASIS ON WHICH YOU MAY ACCESS THE SUPPLEMENTARY PROSPECTUS AND BASE PROSPECTUS

Please note that the information contained in the Supplementary Prospectus and the Base Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus you must ascertain from the Base Prospectus whether or not you are part of the intended addressees of the information contained therein. Your right to access this service is conditional upon complying with the above requirements.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIPGGBPUUPCGRM

a d v e r t i s e m e n t